Literature DB >> 3047204

Protein modification in aging.

E R Stadtman1.   

Abstract

The age-related accumulation of abnormal forms of enzymes is attributable to posttranslational modification of protein structure and to a progressive loss with age of proteases that preferentially degrade the modified forms. The protein modifications include, but are not limited to: the oxidation of amino acid side chains (especially, side chains of prolyl, arginyl, lysyl and histidinyl residues) by mixed-function oxidation systems; the deamidation of asparaginyl and glutaminyl residues; the racemization and isomerization of aspartyl and asparaginyl residues; the isomerization of prolyl residues; the oxidation of cysteine sulfhydryl groups; and spontaneous changes in protein conformation that are apparently unlinked to changes in amino acid composition. Evidence supporting the roles of these protein modifications and of the proteases that degrade abnormal enzymes during aging is discussed, as well as a consideration of some technical limitations of the methods used in their study.

Mesh:

Substances:

Year:  1988        PMID: 3047204     DOI: 10.1093/geronj/43.5.b112

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  28 in total

1.  A protein methyltransferase specific for altered aspartyl residues is important in Escherichia coli stationary-phase survival and heat-shock resistance.

Authors:  C Li; S Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 2.  p53, oxidative stress, and aging.

Authors:  Dongping Liu; Yang Xu
Journal:  Antioxid Redox Signal       Date:  2011-02-07       Impact factor: 8.401

Review 3.  Clinical Relevance of Biomarkers of Oxidative Stress.

Authors:  Jeroen Frijhoff; Paul G Winyard; Neven Zarkovic; Sean S Davies; Roland Stocker; David Cheng; Annie R Knight; Emma Louise Taylor; Jeannette Oettrich; Tatjana Ruskovska; Ana Cipak Gasparovic; Antonio Cuadrado; Daniela Weber; Henrik Enghusen Poulsen; Tilman Grune; Harald H H W Schmidt; Pietro Ghezzi
Journal:  Antioxid Redox Signal       Date:  2015-10-26       Impact factor: 8.401

4.  Suppression of the osteogenic response in the aging skeleton.

Authors:  C T Rubin; S D Bain; K J McLeod
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

5.  Activation of proteasome by insulin-like growth factor-I may enhance clearance of oxidized proteins in the brain.

Authors:  Elizabeth Crowe; Christian Sell; Jeff D Thomas; Gregg J Johannes; Claudio Torres
Journal:  Mech Ageing Dev       Date:  2009 Nov-Dec       Impact factor: 5.432

6.  The "normal" brain. "Abnormal" ubiquitinilated deposits highlight an age-related protein change.

Authors:  M A Pappolla; R Omar; B Saran
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

Review 7.  Mitophagy in maintaining skeletal muscle mitochondrial proteostasis and metabolic health with ageing.

Authors:  Joshua C Drake; Zhen Yan
Journal:  J Physiol       Date:  2017-09-24       Impact factor: 5.182

8.  Age-associated, oxidatively modified proteins: A critical evaluation.

Authors:  S Goto; A Nakamura
Journal:  Age (Omaha)       Date:  1997-04

9.  Assessment of mitochondrial biogenesis and mTORC1 signaling during chronic rapamycin feeding in male and female mice.

Authors:  Joshua C Drake; Frederick F Peelor; Laurie M Biela; Molly K Watkins; Richard A Miller; Karyn L Hamilton; Benjamin F Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-08       Impact factor: 6.053

Review 10.  Proteomic approaches to quantify cysteine reversible modifications in aging and neurodegenerative diseases.

Authors:  Liqing Gu; Renã A S Robinson
Journal:  Proteomics Clin Appl       Date:  2016-11-11       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.